Chemoinformaics analysis of Z,Z,Z-1,4,6,9-Nonadecatetraene
| Molecular Weight | 260.465 | nRot | 13 |
| Heavy Atom Molecular Weight | 228.209 | nRig | 4 |
| Exact Molecular Weight | 260.25 | nRing | 0 |
| Solubility: LogS | -4.705 | nHRing | 0 |
| Solubility: LogP | 6.532 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 53.0674 |
| nHD | 0 | BPOL | 32.1026 |
| QED | 0.195 |
| Synth | 2.774 |
| Natural Product Likeliness | 1.656 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.024 |
| CACO-2 | -4.729 |
| MDCK | 0.0000326 |
| BBB | 0.774 |
| PPB | 1.00098 |
| VDSS | 3.213 |
| FU | 0.00915426 |
| CYP1A2-inh | 0.866 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.759 |
| CYP2c19-sub | 0.619 |
| CYP2c9-inh | 0.405 |
| CYP2c9-sub | 0.277 |
| CYP2d6-inh | 0.885 |
| CYP2d6-sub | 0.463 |
| CYP3a4-inh | 0.941 |
| CYP3a4-sub | 0.21 |
| CL | 7.073 |
| T12 | 0.825 |
| hERG | 0.611 |
| Ames | 0.363 |
| ROA | 0.022 |
| SkinSen | 0.974 |
| Carcinogencity | 0.444 |
| EI | 0.976 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.588101 |